Miss Zion Gibbs, FNP-BC | |
7920 Mcdonogh Rd Ste 201, Owings Mills, MD 21117 | |
(855) 527-7246 | |
(866) 229-5063 |
Full Name | Miss Zion Gibbs |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 7920 Mcdonogh Rd Ste 201, Owings Mills, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316643695 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 11021931 (Florida) | Secondary |
363LF0000X | Nurse Practitioner - Family | AC005891 (Maryland) | Primary |
Entity Name | Sharpe Medical Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154714129 PECOS PAC ID: 0446510465 Enrollment ID: O20180501002033 |
News Archive
In a new study published in Cancer Epidemiology, Associate Professor Dr. Cara Frankenfeld of the George Mason College of Health and Human Services found racial disparities in how the presence of cancer-related diagnostic and treatment technology is related to colorectal cancer patient outcomes in Georgia.
In a new study published in the journal Human Immunology, scientists sought to better understand how B-cell immune repertoire changes over time during SARS-CoV-2 infection by comprehensively characterizing the dynamics of immunoglobin heavy chain (IGH) repertoire in COVID-19 patients.
Simulations of large-scale networks of neurons are a key element in the European Human Brain Project. In a new perspective article scientists from the HBP argue why such simulations are indispensable for bridging the scales between the neuron and system levels in the brain.
By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.
AltheRx Pharmaceuticals, a privately-held clinical development company, presented positive results from its Phase II study of Solabegron in overactive bladder (OAB) at the European Association of Urology Congress in Paris.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Miss Zion Gibbs, FNP-BC 201 Defense Hwy Ste 205, Annapolis, MD 21401-7096 Ph: (855) 527-7246 | Miss Zion Gibbs, FNP-BC 7920 Mcdonogh Rd Ste 201, Owings Mills, MD 21117 Ph: (855) 527-7246 |
News Archive
In a new study published in Cancer Epidemiology, Associate Professor Dr. Cara Frankenfeld of the George Mason College of Health and Human Services found racial disparities in how the presence of cancer-related diagnostic and treatment technology is related to colorectal cancer patient outcomes in Georgia.
In a new study published in the journal Human Immunology, scientists sought to better understand how B-cell immune repertoire changes over time during SARS-CoV-2 infection by comprehensively characterizing the dynamics of immunoglobin heavy chain (IGH) repertoire in COVID-19 patients.
Simulations of large-scale networks of neurons are a key element in the European Human Brain Project. In a new perspective article scientists from the HBP argue why such simulations are indispensable for bridging the scales between the neuron and system levels in the brain.
By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.
AltheRx Pharmaceuticals, a privately-held clinical development company, presented positive results from its Phase II study of Solabegron in overactive bladder (OAB) at the European Association of Urology Congress in Paris.
› Verified 6 days ago